Amanda Corbett

Home > Faculty & Research > Faculty Directory > Amanda Corbett

Document Actions

Publications

1. Min SS, Corbett AH, Rezk NL, Cu-Uvin S, Fiscus SA, Petch L, Cohen MS, Kashuba ADM. Protease inhibitor and non-nucleoside reverse transcriptase inhibitor concentrations in the genital tract of HIV-1 infected women. J Acquir Immun Defic Syndr 2004;37:1577-80.

2. Corbett AH, Eron JJ, Fiscus SA, Rezk NL, Kashuba ADM. The pharmacokinetics, safety, and initial virologic response of a triple-protease inhibitor salvage regimen containing amprenavir, saquinavir, and ritonavir. J Acquir Immun Defic Syndr 2004;36:921-928.

3. Catanzaro L, Corbett A, Kashuba A, Shafer R, Hewitt RG, Acosta E, and Morse GD. HIV-1 Protease Inhibitors, in Antimicrobial Therapy and Vaccines, Vol. II. Yu VL, et al. (eds), New York: Apple Trees Production, 2003.

4. Corbett AH, Kashuba ADM. Ask the Experts - Combining Saquinavir with Lopinavir/ritonavir. www.medscape.com, Sept 2002.

5. Corbett AH, Lim ML, Kashuba, ADM. Kaletra (Lopinavir/Ritonavir). Annals of
Pharmacotherapy, 2002;36(7/8):1193-1203.

6. Corbett AH, Kashuba ADM. Fosamprenavir. Current Opinion in Investigational
        Drugs, 2002;3(3):384-390.

7. Corbett AH, Kashuba ADM. Ask the Experts – Treatment of Nelfinavir-
Associated Diarrhea. www.medscape.com, Jan 2002